KRas Localizes to the Plasma Membrane by Spatial Cycles of Solubilization, Trapping and Vesicular Transport

Schmick, Malte, Vartak, Nachiket, Papke, Björn, Kovacevic, Marija, Truxius, Dina C., Rossmannek, Lisaweta, Bastiaens, Philippe I.H.·2014·Cell
DOI 10.1016/j.cell.2014.02.051

Cited by (246)

Items 101–200 of 246

  1. Structure-based development of PDEδ inhibitors
    Pablo Martín‐Gago, Eyad K. Fansa, Alfred Wittinghofer, Herbert Waldmann · 2016 · Biological Chemistry
  2. The G protein–coupled receptor GPR31 promotes membrane association of KRAS
    Nicole Fehrenbacher, Israel Tojal da Silva, Craig Ramírez, Yong Zhou, Kwang-Jin Cho, Shafi Kuchay, Jie Shi, Susan Thomas, Michele Pagano, John F. Hancock et al. · 2017 · The Journal of Cell Biology
  3. Dynamic Regulation of Expression of KRAS and Its Effectors Determines the Ability to Initiate Tumorigenesis in Pancreatic Acinar Cells
    Mohamad Assi, Younès Achouri, Axelle E. Loriot, Nicolas Dauguet, Hajar Dahou, Jonathan Baldan, Maxime Libert, Jean S. Fain, Carmen E. Guerra, Luc Bouwens et al. · 2021 · Cancer Research
  4. Direct Modulators of K-Ras–Membrane Interactions
    Johannes Morstein, Rebika Shrestha, Que N. Van, César A. López, Neha Arora, Marco Tonelli, Liang Hong, De Chen, Yong Zhou, John F. Hancock et al. · 2023 · ACS Chemical Biology
  5. Chemical Biology Tools for Regulating RAS Signaling Complexity in Space and Time
    Hilde van Hattum, Herbert Waldmann · 2014 · Chemistry & Biology
  6. Oncogenic KRas mobility in the membrane and signaling response
    Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang · 2018 · Seminars in Cancer Biology
  7. Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS Signaling
    Tamas Yelland, Esther García, Charles Parry, Dominika Kowalczyk, Marta Wojnowska, Andrea Gohlke, Matja Zalar, Kenneth Cameron, Gillian Goodwin, Qing Yu et al. · 2022 · Journal of Medicinal Chemistry
  8. Peptide-Mediated Small Molecule Lysosome-Targeting Chimeras for Targeted Degradation of Membrane and Intracellular Proteins
    Shuqiang Chen, Wei Wang, Zhipeng Chen, Ruyan Li, Zhe Wu, Guoqiang Dong, Chunquan Sheng · 2024 · Journal of Medicinal Chemistry
  9. Higher order signaling: ARL2 as regulator of both mitochondrial fusion and microtubule dynamics allows integration of 2 essential cell functions
    Joshua W. Francis, Rachel E. Turn, Laura E. Newman, Cara R. Schiavon, Richard Kahn · 2016 · Small GTPases
  10. Multidirectional Activity Control of Cellular Processes by a Versatile Chemo‐optogenetic Approach
    Xi Chen, Muthukumaran Venkatachalapathy, Leif Dehmelt, Yao‐Wen Wu · 2018 · Angewandte Chemie International Edition
  11. An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth
    Pelin Kaya, Elisabeth Schaffner‐Reckinger, Ganesh babu Manoharan, Vladimir Vukić, Alexandros Kiriazis, Mirko Ledda, Maria Burgos Renedo, Karolina Pavic, Anthoula Gaigneaux, Enrico Glaab et al. · 2024 · Journal of Medicinal Chemistry
  12. An oxanthroquinone derivative that disrupts RAS plasma membrane localization inhibits cancer cell growth
    Lingxiao Tan, Kwang-Jin Cho, Pratik Neupane, Robert J. Capon, John F. Hancock · 2018 · Journal of Biological Chemistry
  13. Acylpeptide hydrolase is a novel regulator of KRAS plasma membrane localization and function
    Lingxiao Tan, Kwang‐Jin Cho, Walaa E. Kattan, Christian M. Garrido, Yong Zhou, Pratik Neupane, Robert J. Capon, John F. Hancock · 2019 · Journal of Cell Science
  14. Galectin-8 binds to the Farnesylated C-terminus of K-Ras4B and Modifies Ras/ERK Signaling and Migration in Pancreatic and Lung Carcinoma Cells
    Christopher Meinohl, Sarah J. Barnard, Karin Fritz‐Wolf, Monika Unger, Andreea Porr, Marisa Heipel, Stefanie Wirth, Johannes Madlung, Alfred Nordheim, André Menke et al. · 2019 · Cancers
  15. Mechanism and dynamics of INPP5E transport into and inside the ciliary compartment
    Stefanie Kristine Kösling, Eyad K. Fansa, Stefano Maffini, Alfred Wittinghofer · 2017 · Biological Chemistry
  16. RAS Nanoclusters Selectively Sort Distinct Lipid Headgroups and Acyl Chains
    Yong Zhou, Alemayehu Abebe Gorfe, John F. Hancock · 2021 · Frontiers in Molecular Biosciences
  17. Translocation of an Intracellular Protein via Peptide-Directed Ligation
    Christiane Stiller, Dennis M. Krüger, Nicolas Brauckhoff, Marcel Schmidt, Petra Janning, Hazem Salamon, Tom N. Grossmann · 2016 · ACS Chemical Biology
  18. A self-organized synthetic morphogenic liposome responds with shape changes to local light cues
    Konstantin Gavriljuk, Bruno Scocozza, Farid Ghasemalizadeh, Hans Seidel, Akhilesh P. Nandan, Manuel Campos-Medina, Malte Schmick, Aneta Koseska, Philippe I. H. Bastiaens · 2021 · Nature Communications
  19. RPGR, a prenylated retinal ciliopathy protein, is targeted to cilia in a prenylation- and PDE6D-dependent manner
    Nirmal Dutta, Seongjin Seo · 2016 · Biology Open
  20. KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic Adenocarcinoma
    Minh T. Than, Mark H. O’Hara, Ben Z. Stanger, Kim A. Reiss · 2024 · Molecular Cancer Therapeutics
  21. Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
    Kuen Kuen Lam, Siew Heng Wong, Peh Yean Cheah · 2023 · Cells
  22. Small‐Molecule Inhibition of the UNC119–Cargo Interaction
    Tom Mejuch, Guillaume Garivet, Walter Hofer, Nadine Kaiser, Eyad K. Fansa, Christiane Ehrt, Oliver Koch, Matthias Baumann, Slava Ziegler, Alfred Wittinghofer et al. · 2017 · Angewandte Chemie International Edition
  23. New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling
    Keesha E. Erickson, Oleksii S. Rukhlenko, Richard G. Posner, William S. Hlavacek, Boris Ν. Kholodenko · 2018 · Seminars in Cancer Biology
  24. Protein lipidation in the tumor microenvironment: enzymology, signaling pathways, and therapeutics
    Mengke Xu, Bo Xu · 2025 · Molecular Cancer
  25. S-acylation of NLRP3 provides a nigericin sensitive gating mechanism that controls access to the Golgi
    Daniel M. Williams, Andrew A. Peden · 2024 · eLife
  26. Small-Molecule Modulation of Lipid-Dependent Cellular Processes against Cancer: Fats on the Gunpoint
    Aswin T. Srivatsav, Manjari Mishra, Shobhna Kapoor · 2018 · BioMed Research International
  27. Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
    Michael Dumbacher, Tom Van Dooren, Katrien Princen, Koen De Witte, Mélissa Farinelli, Sam Lievens, Jan H. Tavernier, Wim Dehaen, Stefaan Wera, Joris Winderickx et al. · 2018 · Molecular Neurodegeneration
  28. The Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma Progression
    Peter Dietrich, Claus Hellerbrand, Anja‐Katrin Bosserhoff · 2019 · Cancers
  29. UBIAD1 suppresses the proliferation of bladder carcinoma cells by regulating H-Ras intracellular trafficking via interaction with the C-terminal domain of H-Ras
    Zhiliang Xu, Fengsen Duan, Huiai Lu, Maytham Abdul Kadhim Dragh, Yanzhi Xia, Huageng Liang, Ling Hong · 2018 · Cell Death and Disease
  30. The N‐ and C‐terminal ends of RPGR can bind to PDE6δ
    Eyad K. Fansa, Nicola O’Reilly, Shehab Ismail, Alfred Wittinghofer · 2015 · EMBO Reports
  31. The EGFR phosphatase RPTPγ is a redox‐regulated suppressor of promigratory signaling
    Maitreyi S. Joshi, Angel Stanoev, Jan Huebinger, Birga Soetje, Veronika Zorina, Lisaweta Roßmannek, Kirsten Michel, Sven AH Müller, Philippe I. H. Bastiaens · 2023 · The EMBO Journal
  32. Progress in RAS‐targeted therapeutic strategies: From small molecule inhibitors to proteolysis targeting chimeras
    Xinchen Lu, Jinmei Jin, Ye Wu, Xiaoxia Liu, Xiaohui Liang, Jiayi Lin, Qingyan Sun, Jiang‐Jiang Qin, Weidong Zhang, Xin Luan · 2023 · Medicinal Research Reviews
  33. Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling
    Christian M. Garrido, Karen M. Henkels, Kristen M. Rehl, Liang Hong, Yong Zhou, Jordan U. Gutterman, Kwang‐Jin Cho · 2020 · Scientific Reports
  34. Correlation of O2 transport on the micro and macro scale.
    Carl R. Honig, T. E. Gayeski · 1982 · PubMed
  35. Targeted Degradation Technologies Utilizing Autophagy
    Zeyu Zhou, Jiaming Liang, Binghua Cheng, Yanyan Li, Wenjie Zhou, Hui Tian, Wenli Shi, Ke Liu, Lijing Fang, Hongchang Li et al. · 2025 · International Journal of Molecular Sciences
  36. Selected Approaches to Disrupting Protein–Protein Interactions within the MAPK/RAS Pathway
    Stephen J. Harwood, Christopher R. Smith, J. David Lawson, John M. Ketcham · 2023 · International Journal of Molecular Sciences
  37. RAS G-domains allosterically contribute to the recognition of lipid headgroups and acyl chains
    Neha Arora, Huanwen Mu, Hong Liang, Wenting Zhao, Yong Zhou · 2024 · The Journal of Cell Biology
  38. Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancer
    Hsiao-Ching Chuang, Po-Hsien Huang, Samuel Kiyota Kulp, Ching‐Shih Chen · 2017 · Pharmacological Research
  39. Mechanistic insights into the role of prenyl-binding protein PrBP/δ in membrane dissociation of phosphodiesterase 6
    Bilal Muhammad Qureshi, Andrea Schmidt, Elmar Behrmann, Jörg Bürger, Thorsten Mielke, Christian M. T. Spahn, Martin Heck, Patrick Scheerer · 2018 · Nature Communications
  40. Depletion of phosphatidylinositol 4-phosphate at the Golgi translocates K-Ras to mitochondria
    Taylor E. Miller, Karen M. Henkels, Mary Huddleston, Richard L. Salisbury, Saber M. Hussain, Atsuo T. Sasaki, Kwang‐Jin Cho · 2019 · Journal of Cell Science
  41. Influence of Cholesterol on the Orientation of the Farnesylated GTP-Bound KRas-4B Binding with Anionic Model Membranes
    Huixia Lu, Jordi Martı́ · 2020 · Membranes
  42. Predicting the conformational variability of oncogenic GTP-bound G12D mutated KRas-4B proteins at zwitterionic model cell membranes
    Huixia Lu, Jordi Martı́ · 2022 · Nanoscale
  43. The Function of Embryonic Stem Cell-expressed RAS (E-RAS), a Unique RAS Family Member, Correlates with Its Additional Motifs and Its Structural Properties
    Saeideh Nakhaei‐Rad, Hossein Nakhaeizadeh, Claus Kordes, Ion Cristian Cirstea, Malte Schmick, Radovan Dvorský, Philippe I. H. Bastiaens, Dieter Häussinger, Mohammad Reza Ahmadian · 2015 · Journal of Biological Chemistry
  44. Role of epigenetic factors in the selection of the alternative splicing isoforms of human KRAS in colorectal cancer cell lines
    Ángela L. Riffo‐Campos, Francisco Gimeno-Valiente, Fernanda M. Rodríguez, Andrès M.R. Cervantes, Gerardo López‐Rodas, Luís Franco, Josefa Castillo · 2018 · Oncotarget
  45. NMR in integrated biophysical drug discovery for RAS: past, present, and future
    Christopher B. Marshall, Fenneke KleinJan, Teklab Gebregiworgis, Ki‐Young Lee, Zhenhao Fang, Ben J. Eves, Ningdi F. Liu, Geneviève M. C. Gasmi-Seabrook, Masahiro Enomoto, Mitsuhiko Ikura · 2020 · Journal of Biomolecular NMR
  46. Palmitoylation and PDE6δ regulate membrane-compartment-specific substrate ubiquitylation and degradation
    David Liang, Liping Jiang, Sameer Ahmed Bhat, Sonia Missiroli, Mariasole Perrone, Angela Lauriola, Ritika Adhikari, Anish Gudur, Zahra Vasi, Ian M. Ahearn et al. · 2023 · Cell Reports
  47. Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma
    Xiaoyu Liu, Wan Xie, Silu Meng, Xiaoyan Kang, Yuhuan Liu, Lili Guo, Changyu Wang · 2022 · Cells
  48. FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage
    Hanna Parkkola, Farid Ahmad Siddiqui, Christina Oetken-Lindholm, Daniel Abankwa · 2021 · Methods in molecular biology
  49. S-acylation of NLRP3 provides a nigericin sensitive gating mechanism that controls access to the Golgi
    Daniel M. Williams, Andrew A. Peden · 2024 · eLife
  50. Spatiotemporal imaging of small GTPases activity in live cells
    Stephanie Voß, Dennis M. Krüger, Oliver Koch, Yao‐Wen Wu · 2016 · Proceedings of the National Academy of Sciences
  51. Ras functional proximity proteomics establishes mTORC2 as new direct ras effector
    Joanna R. Kovalski, Ronald L. Shanderson, Paul A. Khavari · 2019 · Oncotarget
  52. Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity
    Karen M. Henkels, Kristen M. Rehl, Kwang‐Jin Cho · 2021 · Frontiers in Molecular Biosciences
  53. Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation
    Chandra Kumar Elechalawar, Geeta Rao, Suresh Kumar Gulla, Maulin Mukeshchandra Patel, Alex N. Frickenstein, Nicolas Means, Ram Vinod Roy, Leonidas Tsiokas, Sima Asfa, Prasanta Panja et al. · 2023 · ACS Nano
  54. Phosphocode-dependent glutamyl-prolyl-tRNA synthetase 1 signaling in immunity, metabolism, and disease
    Eun-Young Lee, Jungwon Hwang, Myung Hee Kim · 2023 · Experimental & Molecular Medicine
  55. DFT and molecular simulation validation of the binding activity of PDEδ inhibitors for repression of oncogenic k-Ras
    Taghreed A. Majrashi, Ahmed Sabt, Hadia Almahli, Mahmoud A. El Hassab, Mahmoud A. Noamaan, Eslam B. Elkaeed, Mohamed Farouk Hamissa, Abdalkareem Nael Jameel Maslamani, Moataz Ahmed Shaldam, Wagdy Mohamed Eldehna · 2024 · PLoS ONE
  56. The Structural and Biochemical Characterization of UNC119B Cargo Binding and Release Mechanisms
    Tamas Yelland, Esther García, Youhani Samarakoon, Shehab Ismail · 2021 · Biochemistry
  57. Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ
    E. Sıla Özdemir, Hyunbum Jang, Attila Gürsoy, Özlem Keskin, Ruth Nussinov · 2018 · The Journal of Physical Chemistry B
  58. Structural basis of Gip1 for cytosolic sequestration of G protein in wide-range chemotaxis
    Takero Miyagawa, Hiroyasu Koteishi, Yoichiro Kamimura, Yukihiro Miyanaga, Kohei Takeshita, Atsushi Nakagawa, Masahiro Ueda · 2018 · Nature Communications
  59. A spatially regulated GTPase cycle of Rheb controls growth factor signaling to mTORC1
    Marija Kovačević, Christian H. Klein, Lisaweta Roßmannek, Antonios D. Konitsiotis, Angel Stanoev, Astrid Kraemer, Philippe I. H. Bastiaens · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Targeting endogenous K-RAS for degradation through the affinity-directed protein missile system
    Sascha Röth, Thomas Macartney, Agnieszka Konopacka, Markus A. Queisser, Gopal P. Sapkota · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  61. KRAS4B oncogenic mutants promote non-small cell lung cancer progression via the interaction of deubiquitinase USP25 with RNF31
    Ci Yang, Hong-Xu Li, Hu Gan, Xin Shuai, Chen Dong, Wei J. Wang, Dandan Lin, Bo Zhong · 2025 · Developmental Cell
  62. A PDE6δ‐KRas Inhibitor Chemotype with up to Seven H‐Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2
    Pablo Martín‐Gago, Eyad K. Fansa, Christian H. Klein, Sandip Murarka, Petra Janning, Marc Schürmann, Malte Metz, Shehab Ismail, Carsten Schultz‐Fademrecht, Matthias Baumann et al. · 2017 · Angewandte Chemie
  63. Liquid droplets of protein LAF1 provide a vehicle to regulate storage of the signaling protein K-Ras4B and its transport to the lipid membrane
    Lei Li, Marius Herzog, Simone Möbitz, Roland Winter · 2021 · Physical Chemistry Chemical Physics
  64. Deblurring Signal Network Dynamics
    Dominic Kamps, Leif Dehmelt · 2017 · ACS Chemical Biology
  65. KRAS as Potential Target in Colorectal Cancer Therapy
    Shu-Kee Eng, Teng Hern Tan Loh, Bey Hing Goh, Wai-Leng Lee · 2019 · Springer eBooks
  66. A Novel KRAS Antibody Highlights a Regulation Mechanism of Post-Translational Modifications of KRAS during Tumorigenesis
    Mohamad Assi, Boris Pirlot, Vincent Stroobant, Jean‐Paul Thissen, Patrick Jacquemin · 2020 · International Journal of Molecular Sciences
  67. Untangling the KRAS mutated lung cancer subsets and its therapeutic implications
    Ritu Kulshrestha, Pawan Kumar, Amit Singh, K. Nupur, Sonam Spalgias, Parul Mrigpuri, Rajkumar · 2021 · Molecular Biomedicine
  68. Development of a PDEδ‐Targeting PROTACs that Impair Lipid Metabolism
    Michael Winzker, Alexandra Friese, Uwe Koch, Petra Janning, Slava Ziegler, Herbert Waldmann · 2019 · Angewandte Chemie
  69. Inhibition of K-Ras4B-plasma membrane association with a membrane microdomain-targeting peptide
    Fang-Yi Li, Zhenfeng Zhang, Stephanie Voß, Yao‐Wen Wu, Yufen Zhao, Yanmei Li, Yong‐Xiang Chen · 2019 · Chemical Science
  70. S-acylation regulates the trafficking and stability of the unconventional Q-SNARE STX19
    Khamal Kwesi Ampah, Jennifer Greaves, Amber S. Shun-Shion, Asral Wirda Ahmad Asnawi, Jessica A. Lidster, Luke H. Chamberlain, Mark O. Collins, Andrew A. Peden · 2018 · Journal of Cell Science
  71. Integrated approaches to unravel the impact of protein lipoxidation on macromolecular interactions
    Silvia Zorrilla, Andreia Mónico, Sofía Duarte, Germán Rivas, Dolores Pérez‐Sala, Marı́a A. Pajares · 2019 · Free Radical Biology and Medicine
  72. Small‐Molecule Inhibition of the UNC119–Cargo Interaction
    Tom Mejuch, Guillaume Garivet, Walter Hofer, Nadine Kaiser, Eyad K. Fansa, Christiane Ehrt, Oliver Koch, Matthias Baumann, Slava Ziegler, Alfred Wittinghofer et al. · 2017 · Angewandte Chemie
  73. Multidirectional Activity Control of Cellular Processes by a Versatile Chemo‐optogenetic Approach
    Xi Chen, Muthukumaran Venkatachalapathy, Leif Dehmelt, Yao‐Wen Wu · 2018 · Angewandte Chemie
  74. Probing Colocalization of N‐Ras and K‐Ras4B Lipoproteins in Model Biomembranes
    Lie Li, Mridula Dwivedi, Satyajit Patra, Nelli Erwin, Simone Möbitz, Roland Winter · 2019 · ChemBioChem
  75. Biosynthesis-driven structure–activity relationship study of premonensin-derivatives
    A. Ismail-Ali, Eyad K. Fansa, Niclas Pryk, Samir Yahiaoui, Susanna Kushnir, Marc Pflieger, Alfred Wittinghofer, Frank Schulz · 2016 · Organic & Biomolecular Chemistry
  76. Measuring Cellular Ion Transport by Magnetoencephalography
    Sudhir Kumar Sharma, Sauparnika Vijay, Sangram Gore, Timothy M. Dore, Ramesh Jagannathan · 2020 · ACS Omega
  77. Fast Diffusion Sustains Plasma Membrane Accumulation of Phosphatase of Regenerating Liver-1
    Patricia Castro-Sánchez, Sara Hernández‐Pérez, Óscar Aguilar-Sopeña, Rocia Ramírez-Muñoz, Sandra Rodríguez, Raúl Torres-Ruiz, Pedro Roda‐Navarro · 2020 · Frontiers in Cell and Developmental Biology
  78. Dissociation of the Signaling Protein K‐Ras4B from Lipid Membranes Induced by a Molecular Tweezer
    Lie Li, Nelli Erwin, Simone Möbitz, Felix C. Niemeyer, Thomas H. Schrader, Roland Winter · 2019 · Chemistry - A European Journal
  79. bioPROTACs establish RAS as a degradable target and provide novel RAS biology insights
    Shuhui Lim, Regina Khoo, Yu-Chi Angela Juang, Pooja Gopal, Huibin Zhang, Constance Yeo, Khong Ming Peh, Jinkai Teo, Simon Ng, Brian Henry et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  80. KRas4b–Calmodulin Interaction with Membrane Surfaces: Role of Headgroup, Acyl Chain, and Electrostatics
    Shweta Shree, Mark A. McLean, Andrew G. Stephen, Stephen G. Sligar · 2024 · Biochemistry
  81. Farnesylation-driven KRAS phase separation promotes colon tumor growth
    Xingwen Wang, Yi Zhang, Minqiao Lu, Yafan Gong, Tianqi Guan, Guixue Hou, Yutong Wei, Mao Wang, Hao Liu, Lisha Huang et al. · 2026 · Cell
  82. Drugging Ras trafficking—are there new roads to travel?
    Elisabeth Schaffner‐Reckinger, Atanasio Gómez‐Mulas, Daniel Abankwa · 2025 · npj Drug Discovery.
  83. Synthetic design of farnesyl-electrostatic peptides for development of a protein kinase A membrane translocation switch
    Allen K. Kim, Helen D. Wu, Takanari Inoue · 2021 · Scientific Reports
  84. MTMR regulates KRAS function by controlling plasma membrane levels of phospholipids
    Taylor E. Lange, Ali K. Naji, Ransome van der Hoeven, Hong Liang, Yong Zhou, Gerald R. V. Hammond, John F. Hancock, Kwang‐Jin Cho · 2024 · The Journal of Cell Biology
  85. RAS–membrane interaction and oligomerization: there is more than meets the eye
    Abraham C. Sianoya, Vijay Kumar Bhardwaj, Alemayehu Abebe Gorfe · 2025 · Biochemical Society Transactions
  86. Novel druggable space in human KRAS G13D discovered using structural bioinformatics and a P-loop targeting monoclonal antibody
    Oscar Jungholm, Carolina L. Trkulja, Martin Moche, Sreesha P. Srinivasa, Maria-Nefeli Christakopoulou, Max Davidson, Anna Reymer, Kent E. Jardemark, Rafaela L Fogaça, Anaswara Ashok et al. · 2024 · Scientific Reports
  87. Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
    Zheng Wu, Qing Ye, Shan Zhang, Longgang Hu, Xiao‐Qi Wang, Linli Yao, Lei Zhu, Shu‐Yu Xiao, Zong‐Hao Duan, Xueli Zhang et al. · 2025 · Clinical and Translational Medicine
  88. Intrinsic properties and plasma membrane trafficking route of Src family kinase SH4 domains sensitive to retargeting by HIV-1 Nef
    Amanda J. Chase, Rebecka Wombacher, O. Fackler · 2018 · Journal of Biological Chemistry
  89. S-acylation of NLRP3 provides a nigericin sensitive gating mechanism that controls access to the Golgi
    Daniel M. Williams, Andrew A. Peden · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  90. A new ferrocene derivative blocks K-Ras localization and function by oxidative modification at His95
    Kristen M. Rehl, Jayaraman Selvakumar, Rhonda L. Pitsch, Don Hoang, Kuppuswamy Arumugam, Sean W. Harshman, Alemayehu Abebe Gorfe, Kwang‐Jin Cho · 2023 · Life Science Alliance
  91. KRAS: Structure, function, and development of anticancer drugs
    Dolly A. Parasrampuria, Alex Yu, Nahor Haddish‐Berhane · 2020 · Elsevier eBooks
  92. KRAS Addiction Promotes Cancer Cell Adaptation in Harsh Microenvironment Through Macropinocytosis
    Laetitia Seguin · 2022 · Sub-cellular biochemistry/Subcellular biochemistry
  93. Interaction of KRas4B protein with C6-ceramide containing lipid model membranes
    Lie Li, Mridula Dwivedi, Nelli Erwin, Simone Möbitz, Peter Nußbaumer, Roland Winter · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  94. The Endeavours in RAS Inhibition - the Past, Present, and Future
    Javeena Hussain, Sivapriya Kirubakaran, Srimadhavi Ravi · 2020 · Current Topics in Medicinal Chemistry
  95. The Matter/Life Nexus in Biological Cells
    Vishal Sankar Sivasankar, Roseanna N. Zia · 2025 · Annual Review of Chemical and Biomolecular Engineering
  96. Discovery of Potent PDEδ/NAMPT Dual Inhibitors: Preclinical Evaluation in KRAS Mutant Pancreatic Cancer Cells
    Yaojin Zhu, Zhenqian Chen, Guoyuan Wu, Yuxin Fang, Yuhan Bao, Jiayi Zhu, Guoqiang Dong, Chunquan Sheng, Shipeng He · 2025 · Journal of Medicinal Chemistry
  97. Spatial regulation of ARL3 and GSF ‐mediated lipidated cargo trafficking in the primary cilium
    Hanne Peeters, Shehab Ismail · 2025 · FEBS Letters
  98. Mechanistic insights on spatiotemporal control of Ras-signaling
    Clotilde Charrier, Sascha Mrachacz, Sabrina Schulze, Michael Lammers · 2026 · Biological Chemistry
  99. Insights into direct KRAS inhibition strategies for cancer treatment
    Tong Li, Chenglei Gu, Chen Zhou, Chunqin Mao, Kan Yang, Jinyi Xu, Tulin Lu, Jichao Chen · 2024 · Future Medicinal Chemistry
  100. Gaudichaudion H inhibits KRAS-mutant pancreatic cancer cell growth through interfering PDEδ-KRAS interaction
    Lingyu Li, Qingying Liu, Yuyu Shao, Shuo Wang, Shuangyu Liu, Xiaoning Wang, Shuqi Wang, Dong‐Mei Ren · 2025 · Chemico-Biological Interactions